Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses
Immunovant is ramping up Graves’ disease activity with more batoclimab data and an IMVT-1402 IND clearance.
Autoimmune Disorders
Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases
Pipeline Moves: Investigator-led oncology cell therapy trial terminated
Noxopharm announces launch of autoimmune disease treatment trial
GLP-1 receptor agonists cut risk of death in inflammatory disease patients, says study
Cue Biopharma downsizes to focus on autoimmune pipeline
J&J looks to challenge argenx’s Vyvgart with positive Phase III data
Mozart Therapeutics doses first patients in trial of MTX-101 for autoimmune diseases
